T-cell acute lymphoblastic leukaemia: recent molecular biology findings.

Abstract excerpt

For many years, T-cell acute lymphoblastic leukaemia (T-ALL) has been considered and treated as a single malignancy, but divergent outcomes in T-ALL patients receiving uniform treatment protocols encouraged intensive research on the molecular biology of this disease. Recent findings in the field demonstrate that T-ALL is much more heterogeneous than originally believed and extremely diverse outcomes of patients...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to CpG Islands
• Share to Gene Expression Regulation, Leukemic